Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-12-19 23:40 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$134,750
+35,000 vol $3.85 each |
80,453 | |
Filed 2020-12-19 23:32 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,454,547 vol |
45,453 | |
Filed 2020-12-19 22:43 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-193,941 vol |
6,059 | |
Filed 2020-12-18 14:20 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,000
+60,000 vol $3.85 each |
90,303 | |
Filed 2020-12-18 14:16 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-969,697 vol |
30,303 | |
Filed 2020-12-18 13:48 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
39,425 | |
Filed 2020-12-17 17:06 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
61,060 | |
Filed 2020-12-17 16:59 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-993,940 vol |
31,060 | |
Filed 2020-12-17 16:14 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-16,970 vol |
530 | |
Filed 2020-12-17 14:52 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-40,728 vol |
1,272 | |
Filed 2020-12-17 14:32 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
81,969 | |
Filed 2020-12-17 14:26 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,503,031 vol |
46,969 | |
Filed 2020-12-17 13:41 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,000 vol |
22,091 | |
Filed 2020-12-17 13:38 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-130,909 vol |
4,091 | |
Filed 2020-12-17 12:07 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
33,364 | |
Filed 2020-12-17 12:04 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
39,425 | |
Filed 2020-12-17 11:42 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
347,424 | |
Filed 2020-12-03 16:19 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-606,061 vol |
18,939 | |
Filed 2020-12-03 16:09 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,037,575 vol |
32,425 | |
Filed 2020-12-03 15:18 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-48,485 vol |
1,515 | |
Filed 2020-11-03 17:26 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,037,575 vol |
32,425 | |
Filed 2020-11-02 12:07 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-514,642 vol |
16,083 | |
Filed 2020-11-02 11:57 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-7,117,576 vol |
222,424 | |
Filed 2020-11-02 09:03 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-843,636 vol |
26,364 | |
Filed 2020-01-22 08:22 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+35,000 vol $0.25 each |
135,000 | |
Filed 2020-01-21 12:26 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
1,070,000 | |
Filed 2020-01-20 18:57 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
870,000 | |
Filed 2020-01-20 16:19 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+35,000 vol $0.25 each |
1,070,000 | |
Filed 2019-11-29 12:27 Tx date 2019-11-28 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+100,000 vol $0.25 each |
530,725 | |
Filed 2019-11-02 00:41 Tx date 2019-11-01 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,227
+33,500 vol $0.2456 each |
200,000 | |
Filed 2019-11-01 10:47 Tx date 2019-10-31 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,097
+8,500 vol $0.2468 each |
166,500 | |
Filed 2019-10-29 11:18 Tx date 2019-10-28 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+10,000 vol $0.26 each |
158,000 | |
Filed 2019-10-25 20:00 Tx date 2019-10-24 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+5,000 vol $0.27 each |
50,000 | |
Filed 2019-10-24 19:17 Tx date 2019-10-24 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$390.00
+1,500 vol $0.26 each |
148,000 | |
Filed 2019-10-24 00:10 Tx date 2019-10-22 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+10,000 vol $0.265 each |
146,500 | |
Filed 2019-10-24 00:09 Tx date 2019-10-21 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$675.00
+2,500 vol $0.27 each |
136,500 | |
Filed 2019-10-18 22:59 Tx date 2019-10-17 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,710
+14,000 vol $0.265 each |
134,000 | |
Filed 2019-10-16 18:27 Tx date 2019-10-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+10,000 vol $0.26 each |
120,000 | |
Filed 2019-10-15 22:22 Tx date 2019-10-15 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+10,000 vol $0.28 each |
110,000 | |
Filed 2019-10-13 16:36 Tx date 2019-10-11 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,825
+15,000 vol $0.255 each |
100,000 | |
Filed 2019-10-11 17:34 Tx date 2019-10-11 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,290
+5,000 vol $0.258 each |
45,000 | |
Filed 2019-10-11 17:33 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,680
+10,000 vol $0.268 each |
40,000 | |
Filed 2019-10-10 15:35 Tx date 2019-10-10 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+15,000 vol $0.26 each |
85,000 | |
Filed 2019-10-09 16:47 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,446
+35,000 vol $0.2699 each |
70,000 | |
Filed 2019-10-09 16:46 Tx date 2019-10-07 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,950
+35,000 vol $0.2843 each |
35,000 | |
Filed 2019-10-09 16:41 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-32,500
-50,000 vol $0.65 each |
0 | |
Filed 2019-10-04 12:46 Tx date 2019-10-03 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+5,000 vol $0.28 each |
30,000 | |
Filed 2019-10-01 13:51 Tx date 2019-08-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
Filed 2019-08-16 18:57 Tx date 2019-08-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
Filed 2019-07-11 13:22 Tx date 2019-07-01 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
Filed 2019-07-10 14:27 Tx date 2019-07-10 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,742
+42,000 vol $0.351 each |
42,000 | |
Filed 2019-07-10 14:21 Tx date 2018-03-12 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-04 15:10 Tx date 2019-07-04 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,440
+17,500 vol $0.368 each |
17,500 | |
Filed 2019-07-04 15:08 Tx date 2018-11-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-03 16:18 Tx date 2019-07-03 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,780
+100,000 vol $0.3478 each |
430,725 | |
Filed 2019-05-31 12:54 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,025,000 | |
Filed 2019-05-28 19:17 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Blacher, Joshua Stewart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,775,000 | |
Filed 2019-05-28 18:32 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,000
+400,000 vol $0.435 each |
1,500,000 | |
Filed 2019-05-28 18:18 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,750
+450,000 vol $0.435 each |
1,550,000 | |
Filed 2019-05-28 12:26 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,900
+940,000 vol $0.435 each |
7,340,000 | |
Filed 2019-05-27 17:16 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,250
+150,000 vol $0.435 each |
1,000,000 | |
Filed 2019-03-07 Tx date 2019-03-04 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+255,000 vol $0.60 each |
||
Filed 2019-03-07 Tx date 2019-03-04 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+255,000 vol $0.60 each |
1,100,000 | |
Filed 2019-01-24 Tx date 2019-01-21 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,000
+100,000 vol $0.51 each |
1,100,000 | |
Filed 2019-01-18 Tx date 2019-01-17 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,064
+40,000 vol $0.50 each |
330,725 | |
Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
1,035,000 | |
Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,500
+35,000 vol $0.50 each |
1,035,000 | |
Filed 2019-01-16 Tx date 2019-01-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,917
+10,500 vol $0.4683 each |
290,725 | |
Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
835,000 | |
Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,500
+35,000 vol $0.50 each |
1,035,000 | |
Filed 2019-01-15 Tx date 2019-01-15 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,180
+50,000 vol $0.4836 each |
280,225 | |
Filed 2018-12-10 Tx date 2018-12-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$311,500
+700,000 vol $0.445 each |
700,000 | |
Filed 2018-12-10 Tx date 2018-11-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-31 Tx date 2018-09-07 |
$IN
InMed Pharmaceuticals Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$42,000
+420,000 vol $0.10 each |
||
Filed 2018-10-31 Tx date 2018-09-07 |
$IN
InMed Pharmaceuticals Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$42,000
+420,000 vol $0.10 each |
||
Filed 2018-09-12 Tx date 2018-09-07 |
$IN
InMed Pharmaceuticals Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$42,000
+420,000 vol $0.10 each |
420,000 | |
Filed 2018-09-12 Tx date 2018-09-07 |
$IN
InMed Pharmaceuticals Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,200
+420,000 vol $0.06 each |
3,642,937 | |
Filed 2018-09-12 Tx date 2011-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-09-04 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$221,400
+270,000 vol $0.82 each |
845,000 | |
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-117,000
-150,000 vol $0.78 each |
2,657,500 | |
Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,900
-10,000 vol $0.89 each |
72,786 | |
Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,800
-10,000 vol $0.88 each |
82,786 | |
Filed 2018-08-31 Tx date 2018-04-09 |
$IN
InMed Pharmaceuticals Inc. |
Blacher, Joshua Stewart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,828.80
-29,786 vol $0.80 each |
0 | |
Filed 2018-08-31 Tx date 2018-08-29 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-10,000 vol $0.86 each |
62,786 | |
Filed 2018-08-31 Tx date 2018-04-09 |
$IN
InMed Pharmaceuticals Inc. |
Blacher, Joshua Stewart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,250,000 | ||
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$117,000
+150,000 vol $0.78 each |
||
Filed 2018-08-31 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Blacher, Joshua Stewart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
1,375,000 | |
Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-10,000 vol $0.86 each |
92,786 | |
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-166,000
-200,000 vol $0.83 each |
2,807,500 | |
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,730
-33,000 vol $0.81 each |
29,786 | |
Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$166,000
+200,000 vol $0.83 each |
||
Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,015
-19,500 vol $0.77 each |
192,786 | |
Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,800
-10,000 vol $0.78 each |
162,786 | |
Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-10,000 vol $0.81 each |
152,786 | |
Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-10,000 vol $0.75 each |
264,286 | |
Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,200
-20,000 vol $0.76 each |
244,286 | |
Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-20,000 vol $0.80 each |
172,786 | |
Filed 2018-08-24 Tx date 2018-08-22 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,910
-21,500 vol $0.74 each |
212,286 | |
Filed 2018-08-24 Tx date 2018-08-22 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,095
-1,500 vol $0.73 each |
233,786 | |
Filed 2018-08-24 Tx date 2018-08-24 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-20,000 vol $0.84 each |
132,786 | |
Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,600
-40,000 vol $0.74 each |
274,286 | |
Filed 2018-08-24 Tx date 2018-08-24 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,600
-30,000 vol $0.82 each |
102,786 | |
Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-385.00
-500 vol $0.77 each |
243,786 | |
Filed 2018-08-24 Tx date 2018-08-21 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,205
-8,500 vol $0.73 each |
235,286 | |
Filed 2018-06-22 Tx date 2018-06-21 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$277,781
+222,225 vol $1.25 each |
222,225 | |
Filed 2018-06-22 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-22 Tx date 2018-06-21 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,002
+222,225 vol $0.90 each |
230,225 | |
Filed 2018-05-24 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+100,000 vol $1.02 each |
1,600,000 | |
Filed 2018-05-22 Tx date 2018-05-18 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,000
-200,000 vol $0.13 each |
800,000 | |
Filed 2018-05-22 Tx date 2018-05-18 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,000
+200,000 vol $0.13 each |
314,286 | |
Filed 2018-05-18 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,000
+400,000 vol $1.02 each |
1,000,000 | |
Filed 2018-05-17 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,530,000
+1,500,000 vol $1.02 each |
6,400,000 | |
Filed 2018-05-17 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
575,000 | |
Filed 2018-05-17 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+290,000 vol |
850,000 | |
Filed 2018-03-14 Tx date 2018-03-12 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien Hsu
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
Filed 2018-03-12 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
1,500,000 | |
Filed 2018-03-11 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
600,000 | |
Filed 2018-03-10 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$697,500
+450,000 vol $1.55 each |
4,900,000 | |
Filed 2018-03-10 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
560,000 | |
Filed 2018-02-12 Tx date 2018-02-06 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-54,300
-50,000 vol $1.09 each |
0 | |
Filed 2018-02-05 Tx date 2018-01-30 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-58,630
-50,000 vol $1.17 each |
50,000 | |
Filed 2018-01-17 Tx date 2018-01-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,653.95
-4,700 vol $1.63 each |
0 | |
Filed 2018-01-17 Tx date 2018-01-15 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,490
-1,000 vol $1.49 each |
4,700 | |
Filed 2018-01-16 Tx date 2018-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-289,616.25
-212,500 vol $1.36 each |
100,000 | |
Filed 2018-01-13 Tx date 2018-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,682.90
-9,000 vol $1.30 each |
5,700 | |
Filed 2018-01-12 Tx date 2018-01-11 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,961.88
-9,200 vol $1.41 each |
14,700 | |
Filed 2018-01-11 Tx date 2018-01-10 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,100
-13,000 vol $1.70 each |
23,900 | |
Filed 2018-01-10 Tx date 2018-01-10 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,600
-140,000 vol $0.14 each |
460,000 | |
Filed 2018-01-10 Tx date 2018-01-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-44,747.01
-23,100 vol $1.94 each |
36,900 | |
Filed 2018-01-10 Tx date 2018-01-10 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-233,996
-140,000 vol $1.67 each |
0 | |
Filed 2018-01-10 Tx date 2018-01-10 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,600
+140,000 vol $0.14 each |
140,000 | |
Filed 2018-01-10 Tx date 2016-12-12 |
$IN
InMed Pharmaceuticals Inc. |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,492
-40,000 vol $2.16 each |
60,000 | |
Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,400
-40,000 vol $2.16 each |
||
Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$-562,500
-250,000 vol $2.25 each |
3,007,500 | |
Filed 2018-01-09 Tx date 2018-01-09 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-438,780.50
-219,500 vol $2.00 each |
8,000 | |
Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,324,120.50
-580,500 vol $2.28 each |
227,500 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,750
-27,000 vol $2.25 each |
226,586 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,000
-20,000 vol $2.10 each |
394,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-61,056
-28,800 vol $2.12 each |
365,486 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,600
-20,000 vol $2.13 each |
345,486 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,342
-12,600 vol $2.17 each |
332,886 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-73,584
-33,600 vol $2.19 each |
299,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,000
-5,000 vol $2.20 each |
294,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,100
-10,000 vol $2.21 each |
284,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,200
-10,000 vol $2.22 each |
274,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,115
-500 vol $2.23 each |
273,786 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-45,248
-20,200 vol $2.24 each |
253,586 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,798
-12,300 vol $2.26 each |
214,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,700
-10,000 vol $2.27 each |
204,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,900
-10,000 vol $2.29 each |
194,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,010
-18,700 vol $2.30 each |
175,586 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,003
-1,300 vol $2.31 each |
174,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,200
-10,000 vol $2.32 each |
164,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,300
-10,000 vol $2.33 each |
154,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,400
-10,000 vol $2.34 each |
144,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,600
-20,000 vol $2.38 each |
124,286 | |
Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,100
-10,000 vol $2.41 each |
114,286 | |
Filed 2017-12-15 Tx date 2017-12-12 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$96,000
+100,000 vol $0.96 each |
3,257,500 | |
Filed 2017-11-03 Tx date 2017-11-02 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-92,440
-200,000 vol $0.4622 each |
3,207,500 | |
Filed 2017-11-03 Tx date 2017-11-02 |
$IN
InMed Pharmaceuticals Inc. |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-22,000
-50,000 vol $0.44 each |
3,157,500 | |
Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,100
-10,000 vol $0.41 each |
414,286 | |
Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,252.50
-10,500 vol $0.405 each |
424,286 | |
Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,865
-53,500 vol $0.39 each |
474,286 | |
Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,800
-39,500 vol $0.40 each |
434,786 | |
Filed 2017-10-16 Tx date 2017-10-13 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,990
-6,500 vol $0.46 each |
527,786 | |
Filed 2017-10-16 Tx date 2017-10-12 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,800
-30,000 vol $0.46 each |
534,286 | |
Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,555
-129,500 vol $0.29 each |
564,286 | |
Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,097.50
-10,500 vol $0.295 each |
693,786 | |
Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-10,000 vol $0.30 each |
704,286 | |
Filed 2017-07-27 Tx date 2017-07-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+357,143 vol |
714,286 | |
Filed 2017-07-27 Tx date 2017-07-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-53,571.45
-357,143 vol $0.15 each |
0 | |
Filed 2017-07-11 Tx date 2017-07-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+200,000 vol $0.33 each |
600,000 | |
Filed 2017-07-11 Tx date 2017-07-11 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,400
+20,000 vol $0.32 each |
7,294,572 | |
Filed 2017-06-23 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Muhammad, Ado Hadejia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,250
+25,000 vol $0.45 each |
225,000 | |
Filed 2017-06-08 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$90,000
+200,000 vol $0.45 each |
1,450,000 | |
Filed 2017-06-08 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+100,000 vol $0.45 each |
1,600,000 | |
Filed 2017-06-06 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+50,000 vol $0.45 each |
550,000 | |
Filed 2017-06-06 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$202,500
+450,000 vol $0.45 each |
4,450,000 | |
Filed 2017-06-05 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+100,000 vol $0.45 each |
400,000 | |
Filed 2017-05-31 Tx date 2017-05-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$32,500
+50,000 vol $0.65 each |
50,000 | |
Filed 2017-05-31 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-31 Tx date 2017-05-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
100,000 | |
Filed 2017-05-31 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-09 Tx date 2017-05-05 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
45 - Compensation for property
|
$70,000
+500,000 vol $0.14 each |
3,407,500 | |
Filed 2017-05-02 Tx date 2014-12-01 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-02 Tx date 2014-12-01 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-70,000
-500,000 vol $0.14 each |
||
Filed 2017-05-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
||
Filed 2017-05-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-70,000
-500,000 vol $0.14 each |
||
Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+357,143 vol |
357,143 | |
Filed 2017-04-27 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
||
Filed 2017-04-27 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-70,000
-500,000 vol $0.14 each |
3,025,000 | |
Filed 2017-04-27 Tx date 2017-04-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
+500,000 vol |
1,500,000 | |
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+357,143 vol $0.07 each |
||
Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,000
+357,143 vol $0.07 each |
357,143 | |
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-12 Tx date 2015-03-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Muhammad, Ado Hadejia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2017-03-27 Tx date 2016-07-26 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$55,000
+500,000 vol $0.11 each |
500,000 | |
Filed 2017-03-16 Tx date 2017-03-14 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-92,500 vol |
2,907,500 | |
Filed 2017-03-10 Tx date 2017-02-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,000
+100,000 vol $0.37 each |
500,000 | |
Filed 2017-02-03 Tx date 2016-11-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,652.30
-147,000 vol $0.1609 each |
5,439,680 | |
Filed 2017-02-03 Tx date 2016-12-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+20,000 vol $0.15 each |
5,459,680 | |
Filed 2017-01-24 Tx date 2017-01-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-24 Tx date 2017-01-18 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$18,000
+100,000 vol $0.18 each |
||
Filed 2017-01-24 Tx date 2017-01-18 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$18,000
+100,000 vol $0.18 each |
100,000 | |
Filed 2017-01-17 Tx date 2017-01-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$250,000
+1,000,000 vol $0.25 each |
1,000,000 | |
Filed 2017-01-17 Tx date 2017-01-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Bott, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-03 Tx date 2016-11-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+15,000 vol $0.14 each |
7,645,072 | |
Filed 2017-01-03 Tx date 2016-11-09 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+10,000 vol $0.17 each |
7,655,072 | |
Filed 2017-01-03 Tx date 2016-11-11 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$175.00
+1,000 vol $0.175 each |
7,656,072 | |
Filed 2017-01-03 Tx date 2016-11-14 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$825.00
+5,000 vol $0.165 each |
7,661,072 | |
Filed 2017-01-03 Tx date 2016-11-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,500
+100,000 vol $0.155 each |
7,761,072 | |
Filed 2017-01-03 Tx date 2016-12-01 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+20,000 vol $0.15 each |
7,781,072 | |
Filed 2017-01-03 Tx date 2016-12-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,950
+93,000 vol $0.15 each |
7,874,072 | |
Filed 2017-01-03 Tx date 2016-12-05 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72.50
+500 vol $0.145 each |
7,874,572 | |
Filed 2017-01-03 Tx date 2016-12-29 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,000
-100,000 vol $0.26 each |
7,774,572 | |
Filed 2016-12-13 Tx date 2016-12-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-13 Tx date 2016-12-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Charpentier, Jeff
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,000
+300,000 vol $0.14 each |
300,000 | |
Filed 2016-11-18 Tx date 2016-11-15 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,750
+750,000 vol $0.165 each |
1,750,000 | |
Filed 2016-11-18 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+500,000 vol $0.195 each |
500,000 | |
Filed 2016-11-17 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-07 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+500,000 vol $0.195 each |
1,500,000 | |
Filed 2016-11-07 Tx date 2016-07-26 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$55,000
+500,000 vol $0.11 each |
1,000,000 | |
Filed 2016-11-04 Tx date 2016-11-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+20,000 vol $0.145 each |
7,630,072 | |
Filed 2016-11-04 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
Filed 2016-11-04 Tx date 2015-11-23 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
312,500 | ||
Filed 2016-11-04 Tx date 2016-11-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+25,000 vol $0.16 each |
7,610,072 | |
Filed 2016-11-01 Tx date 2016-10-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+625,000 vol $0.08 each |
625,000 | |
Filed 2016-11-01 Tx date 2016-10-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$170,000
+2,125,000 vol $0.08 each |
5,586,680 | |
Filed 2016-11-01 Tx date 2016-09-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-10-31 Tx date 2016-10-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
7,585,072 | |
Filed 2016-10-31 Tx date 2016-10-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$925.00
+5,000 vol $0.185 each |
7,535,072 | |
Filed 2016-10-31 Tx date 2016-10-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238,000
+2,975,000 vol $0.08 each |
7,530,072 | |
Filed 2016-10-31 Tx date 2016-10-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-238,000
-1,400,000 vol $0.17 each |
4,555,072 | |
Filed 2016-10-27 Tx date 2016-10-26 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-170,000
-1,000,000 vol $0.17 each |
3,461,680 | |
Filed 2016-10-27 Tx date 2016-10-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,000
-100,000 vol $0.18 each |
4,461,680 | |
Filed 2016-10-21 Tx date 2016-10-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+1,250,000 vol $0.08 each |
4,561,680 | |
Filed 2016-10-06 Tx date 2016-09-23 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,750
-25,000 vol $0.11 each |
5,955,072 | |
Filed 2016-10-06 Tx date 2016-09-23 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,500
-50,000 vol $0.11 each |
||
Filed 2016-10-06 Tx date 2016-09-21 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,000
-50,000 vol $0.10 each |
5,980,072 | |
Filed 2016-10-05 Tx date 2016-09-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,000
-300,000 vol $0.10 each |
3,622,680 | |
Filed 2016-10-05 Tx date 2016-09-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,730
-26,000 vol $0.105 each |
3,596,680 | |
Filed 2016-10-05 Tx date 2016-09-19 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,250
-50,000 vol $0.105 each |
3,546,680 | |
Filed 2016-10-05 Tx date 2016-09-19 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-60,000 vol $0.10 each |
3,486,680 | |
Filed 2016-10-05 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,500
-175,000 vol $0.10 each |
3,311,680 | |
Filed 2016-10-05 Tx date 2016-09-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,900
-399,000 vol $0.10 each |
3,922,680 | |
Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,000
-100,000 vol $0.10 each |
970,000 | |
Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,500
-100,000 vol $0.105 each |
870,000 | |
Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,250
-50,000 vol $0.105 each |
820,000 | |
Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,320
-12,000 vol $0.11 each |
808,000 | |
Filed 2016-10-03 Tx date 2016-09-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
Filed 2016-09-26 Tx date 2016-07-26 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+750,000 vol $0.11 each |
1,000,000 | |
Filed 2016-09-14 Tx date 2016-06-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$130,000
+1,000,000 vol $0.13 each |
||
Filed 2016-09-14 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+357,143 vol $0.07 each |
1,357,143 | |
Filed 2016-09-14 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
Filed 2016-09-14 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-14 Tx date 2016-06-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$130,000
+1,000,000 vol $0.13 each |
||
Filed 2016-08-17 Tx date 2016-08-17 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,580
+70,000 vol $0.094 each |
1,070,000 | |
Filed 2016-08-05 Tx date 2016-08-05 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+150,000 vol $0.07 each |
6,030,072 | |
Filed 2016-08-05 Tx date 2016-07-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+14,000 vol $0.08 each |
5,880,072 | |
Filed 2016-07-12 Tx date 2016-07-07 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+20,000 vol $0.08 each |
5,866,072 | |
Filed 2016-07-12 Tx date 2016-06-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$910.00
+13,000 vol $0.07 each |
4,339,500 | |
Filed 2016-07-09 Tx date 2016-07-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+10,000 vol $0.09 each |
5,813,072 | |
Filed 2016-07-09 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+10,000 vol $0.115 each |
5,765,072 | |
Filed 2016-07-09 Tx date 2016-06-30 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$475.00
+5,000 vol $0.095 each |
5,770,072 | |
Filed 2016-07-09 Tx date 2016-06-30 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,170
+13,000 vol $0.09 each |
5,783,072 | |
Filed 2016-07-09 Tx date 2016-07-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+20,000 vol $0.095 each |
5,803,072 | |
Filed 2016-07-09 Tx date 2016-07-05 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+20,000 vol $0.09 each |
5,833,072 | |
Filed 2016-06-21 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
Filed 2016-06-21 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-20 Tx date 2016-06-20 |
$IN
INNOVIUM MEDIA PROPERTIES CORP |
Macintosh, James Maitland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns - SD RRSP (Indirect Ownership)
|
Common Shares
97 - Other
|
+90,000 vol |
90,000 | |
Filed 2016-06-20 Tx date 2016-06-20 |
$IN
INNOVIUM MEDIA PROPERTIES CORP |
Macintosh, James Maitland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns - SD RRSP (Indirect Ownership)
|
Common Shares
97 - Other
|
-520,000 vol |
0 | |
Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-20 Tx date 2016-06-15 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,000
+2,000,000 vol $0.11 each |
2,000,000 | |
Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$115,000
+1,000,000 vol $0.115 each |
1,000,000 | |
Filed 2016-06-20 Tx date 2016-06-20 |
$IN
INNOVIUM MEDIA PROPERTIES CORP |
Macintosh, James Maitland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Macquarie Private Wealth - SD RRSP (Indirect Ownership)
|
Common Shares
97 - Other
|
-90,000 vol |
0 | |
Filed 2016-06-15 Tx date 2014-04-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Gieselman, Terese
5 - Senior Officer of Issuer
Holder: Minco Corporate Mgmt Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-15 Tx date 2016-06-09 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$100,000
+1,428,572 vol $0.07 each |
4,321,680 | |
Filed 2016-06-15 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
1,000,000 | |
Filed 2016-06-15 Tx date 2016-05-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$27,500
+250,000 vol $0.11 each |
3,000,000 | |
Filed 2016-06-15 Tx date 2015-11-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hossain, Sazzad
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$35,000
+250,000 vol $0.14 each |
2,750,000 | |
Filed 2016-06-15 Tx date 2016-06-09 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Gieselman, Terese
5 - Senior Officer of Issuer
Holder: Minco Corporate Mgmt Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$13,293
+189,903 vol $0.07 each |
189,903 | |
Filed 2016-06-15 Tx date 2016-06-09 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$100,000
+1,428,572 vol $0.07 each |
5,755,072 | |
Filed 2016-05-18 Tx date 2016-05-17 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+15,000 vol $0.07 each |
4,326,500 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+10,000 vol $0.08 each |
4,311,500 | |
Filed 2016-05-18 Tx date 2016-05-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,150
+42,000 vol $0.075 each |
4,301,500 | |
Filed 2016-05-18 Tx date 2016-05-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+10,000 vol $0.08 each |
4,259,500 | |
Filed 2016-05-18 Tx date 2016-05-11 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+30,000 vol $0.08 each |
4,249,500 | |
Filed 2016-05-09 Tx date 2016-05-06 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,250
+25,000 vol $0.09 each |
4,219,500 | |
Filed 2016-02-23 Tx date 2016-02-11 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$750.00
+5,000 vol $0.15 each |
4,117,000 | |
Filed 2016-02-23 Tx date 2016-02-18 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+12,500 vol $0.14 each |
4,194,500 | |
Filed 2016-02-23 Tx date 2016-02-18 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,750
+50,000 vol $0.155 each |
4,182,000 | |
Filed 2016-02-23 Tx date 2016-02-18 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+15,000 vol $0.14 each |
4,132,000 | |
Filed 2016-02-23 Tx date 2016-02-11 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$850.00
+5,000 vol $0.17 each |
4,112,000 | |
Filed 2016-02-05 Tx date 2016-02-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+45,000 vol $0.16 each |
4,092,000 | |
Filed 2016-02-05 Tx date 2016-02-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$850.00
+5,000 vol $0.17 each |
4,097,000 | |
Filed 2016-02-05 Tx date 2016-02-05 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
4,107,000 | |
Filed 2016-01-26 Tx date 2015-11-23 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2016-01-26 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,000
+50,000 vol $0.14 each |
250,000 | |
Filed 2016-01-11 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
500,000 | |
Filed 2015-12-30 Tx date 2015-12-21 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$320.00
+2,000 vol $0.16 each |
4,047,000 | |
Filed 2015-12-30 Tx date 2015-12-17 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+10,000 vol $0.17 each |
4,045,000 | |
Filed 2015-12-07 Tx date 2015-12-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+10,000 vol $0.195 each |
4,035,000 | |
Filed 2015-12-04 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mansour, Tarek
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,000
+100,000 vol $0.14 each |
225,000 | |
Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
4,025,000 | |
Filed 2015-12-01 Tx date 2015-11-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$652.50
+4,500 vol $0.145 each |
3,505,000 | |
Filed 2015-12-01 Tx date 2015-11-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,375
+25,000 vol $0.135 each |
3,500,500 | |
Filed 2015-12-01 Tx date 2015-11-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+5,000 vol $0.13 each |
3,475,500 | |
Filed 2015-12-01 Tx date 2015-11-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$700.00
+5,000 vol $0.14 each |
3,470,500 | |
Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+100,000 vol $0.30 each |
100,000 | |
Filed 2015-12-01 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+100,000 vol $0.15 each |
1,100,000 | |
Filed 2015-12-01 Tx date 2015-11-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+10,000 vol $0.13 each |
3,515,000 | |
Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+10,000 vol $0.125 each |
3,525,000 | |
Filed 2015-11-30 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
2,500,000 | |
Filed 2015-11-27 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Gieselman, Terese
5 - Senior Officer of Issuer
Holder: Minco Corporate Mgmt Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
$7,000
+50,000 vol $0.14 each |
175,000 | |
Filed 2015-11-18 Tx date 2015-11-17 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,380
+44,000 vol $0.145 each |
3,465,500 | |
Filed 2015-11-04 Tx date 2015-11-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+50,000 vol $0.13 each |
3,421,500 | |
Filed 2015-11-04 Tx date 2015-10-26 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+20,000 vol $0.14 each |
3,371,500 | |
Filed 2015-09-10 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,727
+34,500 vol $0.195 each |
3,220,000 | |
Filed 2015-09-10 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+30,000 vol $0.20 each |
3,351,500 | |
Filed 2015-09-10 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,537
+7,500 vol $0.205 each |
3,321,500 | |
Filed 2015-09-10 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,125
+25,000 vol $0.205 each |
3,314,000 | |
Filed 2015-09-10 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,800
+69,000 vol $0.20 each |
3,289,000 | |
Filed 2015-09-08 Tx date 2015-09-03 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+20,000 vol $0.22 each |
2,820,000 | |
Filed 2015-09-08 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+50,000 vol $0.19 each |
3,185,500 | |
Filed 2015-09-08 Tx date 2015-09-08 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,100
+310,500 vol $0.20 each |
3,135,500 | |
Filed 2015-09-08 Tx date 2015-09-04 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,025
+5,000 vol $0.205 each |
2,825,000 | |
Filed 2015-09-04 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-09-04 Tx date 2015-09-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$205,000
+1,000,000 vol $0.205 each |
1,000,000 | |
Filed 2015-09-01 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
Filed 2015-08-31 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Chris, Bogart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,800,000 | ||
Filed 2015-08-19 Tx date 2015-03-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mansour, Tarek
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,874
+75,000 vol $0.345 each |
125,000 | |
Filed 2015-08-19 Tx date 2015-03-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Puil, Kevin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
78,500 | ||
Filed 2015-08-19 Tx date 2014-07-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mansour, Tarek
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2015-05-13 Tx date 2015-05-07 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$325,000
+1,300,000 vol $0.25 each |
2,893,108 | |
Filed 2015-05-12 Tx date 2015-05-07 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-325,000
-1,300,000 vol $0.25 each |
1,593,108 | |
Filed 2015-05-08 Tx date 2015-05-07 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$250,000
+1,000,000 vol $0.25 each |
2,893,108 | |
Filed 2015-05-08 Tx date 2012-12-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-08 Tx date 2015-05-07 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
schneider, craig douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$200,000
+500,000 vol $0.40 each |
500,000 |